https://oncopeptides.com.haus.se/newsroom/news/ 2026-04-10T16:55:30+00:00 https://oncopeptides.com.haus.se/sv/nyheter/nkengage-grant-projektet-slutfort/ 2026-04-10T16:55:30+00:00 https://oncopeptides.com.haus.se/newsroom/news/nkengage-grant-project-completed/ 2026-04-10T16:54:39+00:00 https://oncopeptides.com.haus.se/newsroom/news/research-shows-that-pepaxti-is-effective-in-high-risk-myeloma/ 2026-04-10T16:42:37+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-secures-fast-track-designation-for-window-of-opportunity-study-in-glioblastoma/ 2026-04-10T16:38:34+00:00 https://oncopeptides.com.haus.se/newsroom/news/european-journal-of-haematology-real-world-data-reinforces-pepaxtis-role-in-treatment-sequencing-for-multiple-myeloma/ 2026-04-09T15:55:11+00:00 https://oncopeptides.com.haus.se/sv/nyheter/vd-sofia-heigis-presenterar-oncopeptides-pa-aktiespararna/ 2026-04-09T15:43:08+00:00 https://oncopeptides.com.haus.se/newsroom/news/video-now-available-oncopeptides-hosted-capital-markets-update-november-13/ 2026-04-09T15:34:54+00:00 https://oncopeptides.com.haus.se/newsroom/news/ceo-sofia-heigis-interviewed-by-redeye-2/ 2026-04-09T15:10:51+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-presented-at-stora-aktiedagarna-an-aktiespararna-event-in-stockholm/ 2026-04-09T15:08:31+00:00 https://oncopeptides.com.haus.se/newsroom/news/ceo-sofia-heigis-interviewed-by-redeye/ 2026-04-09T14:51:54+00:00 https://oncopeptides.com.haus.se/newsroom/news/sofia-heigis-presented-and-interviewed-at-stockholm-corporate-finance-life-science-days/ 2026-04-09T11:40:57+00:00 https://oncopeptides.com.haus.se/newsroom/news/ceo-sofia-heigis-presented-at-redeye-event-commercialization-in-life-science/ 2026-04-09T11:35:38+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-initiates-marina-study-to-strengthen-real-world-evidence-for-pepaxti-in-germany/ 2026-04-07T11:37:29+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-launches-italian-website/ 2026-04-01T13:18:56+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-expands-woda-partnership-with-addition-of-africa-and-eurasia/ 2026-04-01T13:18:47+00:00 https://oncopeptides.com.haus.se/newsroom/news/lotta-larsson-joins-oncopeptides-as-new-head-of-human-resources/ 2026-04-01T13:18:47+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-launches-spanish-website/ 2026-04-01T13:18:45+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-appoints-david-augustsson-as-director-of-corporate-affairs/ 2026-04-01T13:18:38+00:00 https://oncopeptides.com.haus.se/sv/nyheter/vd-sofia-heigis-presenterade-vid-redeye-evenanget-commercialization-in-life-science/ 2026-03-23T11:27:20+00:00 https://oncopeptides.com.haus.se/sv/nyheter/sofia-heigis-presenterade-och-intervjuades-pa-stockholm-corporate-finance-life-science-dagar20-mars-2026/ 2026-03-20T11:36:10+00:00 https://oncopeptides.com.haus.se/newsroom/news/ceo-sofia-heigis-presents-oncopeptides-at-aktiespararna/ 2026-03-17T14:13:47+00:00 https://oncopeptides.com.haus.se/sv/nyheter/oncopeptides-initierar-marina-studie-for-att-starka-real-world-evidens-for-pepaxti-i-tyskland/ 2026-03-16T08:31:24+00:00 https://oncopeptides.com.haus.se/sv/nyheter/european-journal-of-haematology-real-world-data-starker-pepaxtis-roll-i-behandlingssekvensen-vid-multipelt-myelom/ 2026-03-13T10:09:17+00:00 https://oncopeptides.com.haus.se/sv/nyheter/sofia-heigis-presenterar-pa-biostock/ 2026-03-09T09:34:50+00:00 https://oncopeptides.com.haus.se/newsroom/news/biostock-presentation-and-interview-with-sofia-heigis/ 2026-03-09T09:32:46+00:00 https://oncopeptides.com.haus.se/sv/nyheter/oncopeptides-erhaller-fast-track-status-for-window-of-opportunity-studie-i-glioblastom/ 2026-03-09T07:35:40+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-ceo-sofia-heigis-interviewed-by-redeye-about-q4-and-the-new-share-issue/ 2026-03-06T17:10:27+00:00 https://oncopeptides.com.haus.se/sv/nyheter/oncopeptides-vd-sofia-heigis-intervjuad-av-redeye-om-q4-och-nyemissionen/ 2026-02-20T17:09:04+00:00 https://oncopeptides.com.haus.se/sv/nyheter/vd-sofia-heigis-intervjuad-av-redeye/ 2026-01-19T11:51:21+00:00 https://oncopeptides.com.haus.se/sv/nyheter/forskning-visar-att-pepaxti-ar-effektivt-vid-hogriskmyelom/ 2025-12-31T10:34:43+00:00 https://oncopeptides.com.haus.se/sv/nyheter/oncopeptides-presenterade-pa-stora-aktiedagarna-ett-aktiespararna-evenemang-i-stockholm/ 2025-11-27T15:00:41+00:00 https://oncopeptides.com.haus.se/sv/nyheter/video-nu-tillganglig-oncopeptides-anordnade-till-capital-markets-update-13-november/ 2025-11-13T15:23:15+00:00 https://oncopeptides.com.haus.se/newsroom/news/annals-of-hematology-expert-consensus-supports-use-of-pepaxti-in-myeloma/ 2025-11-11T07:31:16+00:00 https://oncopeptides.com.haus.se/newsroom/news/research-by-top-universities-together-with-oncopeptides-on-nk-cell-engagers-to-be-presented-at-ash/ 2025-11-03T14:34:11+00:00 https://oncopeptides.com.haus.se/newsroom/news/exceptional-long-term-responses-to-pepaxti-new-publication-in-journal-of-cancer-research-and-clinical-oncology/ 2025-10-16T12:29:07+00:00 https://oncopeptides.com.haus.se/newsroom/news/new-real-world-data-confirms-efficacy-and-safety-of-pepaxti/ 2025-09-01T08:01:26+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-announces-acceptance-of-spanish-and-italian-real-world-data-at-ims-annual-meeting/ 2025-07-23T11:54:34+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-launches-new-real-world-evidence-study-of-pepaxti-in-spain-first-patient-enrolled/ 2025-05-20T13:01:15+00:00 https://oncopeptides.com.haus.se/newsroom/news/new-real-world-data-support-effectiveness-and-tolerability-of-pepaxti-in-heavily-pretreated-multiple-myeloma-patients/ 2025-04-16T15:21:05+00:00 https://oncopeptides.com.haus.se/newsroom/news/notice-to-annual-general-meeting-at-oncopeptides-ab-publ/ 2025-04-16T06:05:47+00:00 https://oncopeptides.com.haus.se/newsroom/news/fda-removes-clinical-hold-of-oncopeptides-pipeline-drug-opd5/ 2025-04-01T06:30:10+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptalks-first-order-in-italy-and-q4-report/ 2025-03-13T16:18:29+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-receives-first-order-of-pepaxti-in-italy/ 2025-03-11T12:30:38+00:00 https://oncopeptides.com.haus.se/newsroom/news/strong-real-world-efficacy-and-safety-data-with-pepaxti-published-in-the-european-journal-of-haematology/ 2025-02-25T07:30:49+00:00 https://oncopeptides.com.haus.se/newsroom/news/regarding-recent-media-attention/ 2025-02-04T13:58:53+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-pepaxti-formally-approved-for-full-reimbursement-in-italy/ 2025-01-27T09:02:58+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptalks-looking-into-2025/ 2025-01-22T16:16:51+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptalks-2024-in-review/ 2024-12-19T15:36:23+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptalks-meet-the-italian-team/ 2024-12-04T09:42:42+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptalks-on-reimbursement-in-italy/ 2024-11-27T16:55:56+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-obtains-reimbursement-for-pepaxti-in-italy/ 2024-11-27T13:27:42+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-invited-to-present-at-ash-in-december/ 2024-11-20T07:31:13+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptalks-with-special-guest-patrick-jordan-chairman-of-the-world-orphan-drug-alliance/ 2024-10-11T11:15:09+00:00 https://oncopeptides.com.haus.se/newsroom/news/recognizing-the-european-multiple-myeloma-day/ 2024-09-23T14:54:47+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-signs-license-agreement-with-scbio-for-pepaxti-in-south-korea/ 2024-09-12T11:02:18+00:00 https://oncopeptides.com.haus.se/newsroom/news/first-patient-enters-real-world-data-study-in-germany/ 2024-07-22T06:37:25+00:00 https://oncopeptides.com.haus.se/newsroom/news/our-journey-updated-version/ 2024-06-27T11:21:39+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-selects-first-candidate-drug-from-its-spike-platform/ 2024-06-27T06:01:46+00:00 https://oncopeptides.com.haus.se/newsroom/news/first-patients-in-spain-to-be-treated-with-pepaxti/ 2024-05-27T08:53:09+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-presents-new-data-highlighting-treatment-benefits-of-pepaxti-in-high-risk-multiple-myeloma-patients-at-the-comy-congress/ 2024-05-16T07:28:56+00:00 https://oncopeptides.com.haus.se/newsroom/news/clarification-regarding-recent-decision-from-nice/ 2024-04-25T11:05:47+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-secures-national-reimbursement-for-pepaxti-in-spain/ 2024-04-15T11:58:02+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptalks-on-q1-sales-and-mena-partnership/ 2024-04-04T06:22:34+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-and-vector-pharma-fzco-announce-collaboration-to-provide-pepaxti-to-patients-in-the-middle-east-and-north-africa/ 2024-03-27T08:17:54+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-port-study-shows-peripheral-administration-of-pepaxti-being-equally-safe-as-central-venous-administration/ 2024-03-01T16:02:20+00:00 https://oncopeptides.com.haus.se/newsroom/news/pepaxti-provides-sustained-health-related-quality-of-life-ocean-study-shows-article-published-in-haematologica/ 2024-02-29T22:21:24+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-receives-decision-from-the-u-s-food-and-drug-administration-confirming-withdrawal-of-pepaxto-from-the-u-s-market/ 2024-02-23T15:42:00+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-receives-positive-recommendation-for-pepaxti-by-spanish-pricing-authority/ 2024-02-23T09:10:24+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-ensures-five-years-extended-market-exclusivity-for-pepaxti-in-europe/ 2024-02-15T13:03:50+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-ranked-among-the-top-10-companies-in-the-nordic-business-diversity-index-2024/ 2024-02-09T18:49:41+00:00 https://oncopeptides.com.haus.se/newsroom/news/type-ib-variation-process-finalized-original-indication-remains-with-peripheral-administration-included/ 2024-02-07T12:57:30+00:00 https://oncopeptides.com.haus.se/newsroom/news/no-update-from-the-fda-regarding-oncopeptides-appeal/ 2024-01-08T10:11:20+00:00 https://oncopeptides.com.haus.se/newsroom/news/update-on-the-type-ii-application-process/ 2023-12-15T16:45:43+00:00 https://oncopeptides.com.haus.se/newsroom/news/article-with-exploratory-alkylator-refractory-subgroup-analysis-from-oncopeptides-ocean-study-observing-longer-pfs-and-os-in-melflufen-vs-pomalidomide-published-in-european-journal-of-haemat/ 2023-11-17T12:11:50+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-chief-financial-officer-henrik-bergentoft-takes-office-today/ 2023-11-13T10:09:14+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-selected-to-present-additional-data-from-ocean-study-at-the-american-society-of-hematology-meeting/ 2023-11-13T07:32:17+00:00 https://oncopeptides.com.haus.se/newsroom/news/german-price-of-pepaxti-published/ 2023-10-30T09:34:00+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-publishes-article-in-the-journal-of-clinical-pharmacology/ 2023-10-23T09:04:16+00:00 https://oncopeptides.com.haus.se/newsroom/news/update-on-oncopeptides-appeal-of-u-s-withdrawal/ 2023-10-03T08:27:04+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-opts-to-abandon-type-ii-variation-process-for-pepaxti-to-optimize-patient-and-shareholder-value/ 2023-09-28T09:16:39+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-announces-successful-price-negotiations-for-pepaxti-in-germany/ 2023-09-26T07:47:15+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-publishes-article-on-nk-cell-engagers-in-new-biotechnology/ 2023-09-12T10:27:20+00:00 https://oncopeptides.com.haus.se/newsroom/news/oncopeptides-publishes-two-articles-with-results-from-anchor-and-lighthouse-studies-in-haematologica/ 2023-09-04T12:02:12+00:00 https://oncopeptides.com.haus.se/newsroom/news/the-founders-of-oncopeptides-awarded/ 2021-08-26T20:50:02+00:00